High‐grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication—a comprehensive clinical, radiographic, pathologic, and genomic analysis
Authors:
Open Access
- 18 May 2019
- journal article
- research article
- Published by Wiley in Brain Pathology
- Vol. 30 (1) , 46-62
Abstract
High‐grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication (HGNET BCOR ex15 ITD) is a recently proposed tumor entity of the central nervous system (CNS) with a distinct methylation profile and characteristic genetic alteration. The complete spectrum of histologic features, accompanying genetic alterations, clinical outcomes, and optimal treatment for this new tumor entity are largely unknown. Here, we performed a comprehensive assessment of 10 new cases of HGNET BCOR ex15 ITD. The tumors mostly occurred in young children and were located in the cerebral or cerebellar hemispheres. On imaging all tumors were large, well‐circumscribed, heterogeneous masses with variable enhancement and reduced diffusion. They were histologically characterized by predominantly solid growth, glioma‐like fibrillarity, perivascular pseudorosettes, and palisading necrosis, but absence of microvascular proliferation. They demonstrated sparse to absent GFAP expression, no synaptophysin expression, variable OLIG2 and NeuN positivity, and diffuse strong BCOR nuclear positivity. While BCOR exon 15 internal tandem duplication was the solitary pathogenic alteration identified in six cases, four cases contained additional alterations including CDKN2A/B homozygous deletion, TERT amplification or promoter hotspot mutation, and damaging mutations in TP53, BCORL1, EP300, SMARCA2 and STAG2. While the limited clinical follow‐up in prior reports had indicated a uniformly dismal prognosis for this tumor entity, this cohort includes multiple long‐term survivors. Our study further supports inclusion of HGNET BCOR ex15 ITD as a distinct CNS tumor entity and expands the known clinicopathologic, radiographic, and genetic features.Keywords
Funding Information
- NIH Office of the Director (DP5 OD021403)
This publication has 31 references indexed in Scilit:
- BCOR and BCORL1 mutations in myelodysplastic syndromes and related disordersBlood, 2013
- The Somatic Genomic Landscape of GlioblastomaCell, 2013
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomasNature Genetics, 2013
- Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22‐translocationGenes, Chromosomes and Cancer, 2013
- Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomasActa Neuropathologica, 2013
- Medulloblastoma exome sequencing uncovers subtype-specific somatic mutationsNature, 2012
- A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusionNature Genetics, 2012
- Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotypeBlood, 2011
- BCOR regulates mesenchymal stem cell function by epigenetic mechanismsNature Cell Biology, 2009
- Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCORNature Genetics, 2004